Kanzymedipharm develops, manufactures and distributes innovative feed additives from 100% natural sources for farm animals intended to human consumption. It offers the animal industry tailor-made and sustainable solutions to help the animal strengthen its immune system, improve its digestive system and optimize its productive and reproductive system.
To support the livestock industry and help farmers face different challenges of the productivity and protection of their animals, Kanzymedipharm has developed, with the support of University of Guelph, a range of pioneering, natural, non-GMO products.
Plant-extracts, probiotics, prebiotics, enzymes, amino acids and vitamins based products.
Thanks to its network of accredited business partners, Kanzymedipharm possesses a global presence. It is already represented by approximately 21 distributors in three major global regions, the Middle East, North Africa and South America.
Kanzymedipharm is supported by a scientific office in the Middle East and an international network of distributors in several continents. It also continues to receive full support from University of Montreal - Faculty of Medicine in Montreal, QC Canada and University of Guelph in Toronto, ON Canada.
Kanzymedipharm's facilities are successfully certified (Gold category) in GMP and HACCP standards.
Company Details
- Founded
- -
- Address
- 2162 Rue De La Province, Longueuil,quebec J4g,canada
- Industry
- Food Production
- Website
- kanzygroup.com
- HQ
- Longueuil, Quebec
Kanzymedipharm Inc. Questions
Kanzymedipharm Inc.'s website is kanzygroup.com
Kanzymedipharm Inc.'s LinkedIn profile is https://ca.linkedin.com/company/kanzymedipharm-inc
Kanzymedipharm Inc.'s industry is
Food Production
Kanzymedipharm Inc.'s top competitors are
Pace Biopharma,
Bmo Nesbitt Burns,
Solvay,
Rbc Dominion Securities,
Arab Leasing Corporation " Alc ",
Nellson,
Seef World,
Icosia Capital Spa,
Canadian Securities Institute,
Mekhalfia Group.
Kanzymedipharm Inc.'s categories are Food Production
Kanzymedipharm Inc.'s founding year is 1999
